The Complexity of Hormonal Health
Women's hormonal health involves a complex interplay of estrogen, progesterone, testosterone, FSH, LH, cortisol, insulin, and thyroid hormones — all of which fluctuate across the menstrual cycle, through perimenopause, and with lifestyle factors.
Supplements marketed for "hormonal balance" often imply they can uniformly raise or lower hormones as needed, which doesn't reflect how these systems actually work. The more accurate framing is that some compounds may modulate specific aspects of hormonal metabolism or signaling in ways that could benefit particular situations.
DIM (Diindolylmethane)
What it is: DIM is a compound formed when the body metabolizes indole-3-carbinol (I3C) — a glucosinolate found in cruciferous vegetables like broccoli, cabbage, and Brussels sprouts. It is not directly present in food to significant degree; it forms in the acidic environment of the stomach.
Mechanism
DIM promotes a shift in estrogen metabolism toward the "2-hydroxy" pathway (producing 2-OHE1 and 2-OHE2) relative to the "16-alpha-hydroxy" pathway (16α-OHE1). The 2-hydroxy metabolites are considered more favorable for estrogen receptor binding, while 16-alpha metabolites are more potently estrogenic.
DIM also appears to influence aromatase activity (the enzyme that converts androgens to estrogen) and may modulate estrogen receptor alpha and beta activity differently.
Research Evidence
Estrogen metabolite ratios: A 2009 RCT (Nutrition and Cancer, Reed et al.) in 130 women found DIM supplementation (108–900mg/day) dose-dependently shifted urinary estrogen metabolism toward the 2-OHE1 pathway.
Cervical dysplasia/HPV: A 2011 double-blind RCT (Gynecologic Oncology, Del Priore et al.) found DIM significantly improved cervical intraepithelial neoplasia (CIN) 2 and 3 in women positive for HPV at 150mg/day over 24 weeks. This is one of the more interesting findings, though sample size was limited.
Cyclic mastalgia (breast tenderness): A 2014 pilot study found DIM reduced cyclic breast tenderness, potentially through altered estrogen metabolite profiles.
What's less clear: Whether shifting estrogen metabolite ratios translates to meaningful downstream hormonal or clinical outcomes in healthy women with normal estrogen levels. The research is primarily in conditions with abnormal estrogen metabolism or estrogen-sensitive conditions.
DIM is a biologically active compound that affects hormonal pathways. Women with hormone-sensitive conditions (estrogen receptor-positive breast cancer history, hormone-dependent conditions) should consult a physician before using DIM. It should not be assumed to be a simple "estrogen balancer" with no meaningful biological activity.
Vitex (Chaste Tree Berry, Vitex agnus-castus)
What it is: An herb from the Mediterranean traditionally used for menstrual irregularities and PMS.
Mechanism
Vitex acts primarily on dopamine D2 receptors in the pituitary, which reduces prolactin secretion. This can have downstream effects on the LH/FSH balance and progesterone levels. Some research also suggests mild opioid receptor activity.
Research Evidence
PMS and PMDD: A 2001 multicenter, randomized trial (BMJ, Schellenberg, n=178) found Vitex extract Ze 440 (20mg/day for 3 menstrual cycles) significantly reduced PMS symptoms including irritability, mood alteration, headache, bloating, and breast tenderness compared to placebo.
A 2017 meta-analysis (van Die et al., American Journal of Obstetrics and Gynecology) of 17 studies found Vitex superior to placebo for PMS symptom reduction and as effective as various active control interventions.
Cyclic mastalgia: Multiple trials show Vitex effective for cyclic breast tenderness, likely through prolactin reduction. A 2009 Cochrane-style review found good evidence for this application.
Fertility/luteal phase defect: Some research suggests Vitex may support progesterone levels and luteal phase length in women with short luteal phases, potentially through its prolactin-reducing effects. Evidence quality is moderate.
Typical dose: 20–40mg of standardized extract per day, or 160–240mg of dried fruit extract. Effects typically require 2–3 full menstrual cycles.
Maca (Lepidium meyenii)
What it is: A root vegetable/herb from the Peruvian Andes, used historically as a food and fertility aid.
What Research Shows
Sexual function and libido: A 2010 systematic review (Climacteric, Shin et al.) found 4 of 4 identified RCTs reported improvements in sexual dysfunction parameters with maca, though the trials were small and of varying quality.
A 2008 double-blind RCT (Menopause, Brooks et al.) found maca (3.5g/day for 12 weeks) significantly reduced sexual dysfunction scores in postmenopausal women.
Menopausal symptoms: A 2006 observational study and subsequent small RCTs found maca may reduce hot flash frequency and night sweats in perimenopausal women. A 2011 double-blind trial (Menopause, Meissner et al.) found significant reductions in menopausal symptom scores.
What's important to understand: Maca does not appear to contain phytoestrogens or alter sex hormone blood levels measurably in most studies. Its mechanisms for sexual and menopausal effects are not fully understood — potential mechanisms include glucosinolate metabolism and effects on adrenal hormone pathways.
Typical dose: 1.5–3.5g/day of standardized root powder
Evening Primrose Oil
What it is: An oil from Oenothera biennis seeds rich in gamma-linolenic acid (GLA, 8–10% of oil) and linoleic acid. GLA is an omega-6 fatty acid that is a precursor to anti-inflammatory prostaglandin E1.
Research Evidence
Cyclic mastalgia: A 2010 review (Breast Journal) found evening primrose oil modestly reduced cyclic breast pain in several placebo-controlled trials, though effect sizes were smaller than some other interventions. An older 1981 trial by Horrobin was influential but has been questioned.
PMS: Evidence for broader PMS symptom reduction is mixed. Some older positive trials and some negative trials.
Rheumatoid arthritis: Better evidence exists here — multiple RCTs show GLA-containing oils reduce joint pain and morning stiffness. The PUFA Review (Arthritis Research & Therapy, 2003) found positive effects from GLA supplementation.
Hot flashes: A 2013 RCT (Farzaneh et al., n=56 menopausal women) found evening primrose oil significantly reduced hot flash frequency and severity compared to placebo over 8 weeks.
Related: Perimenopause Supplement Support: Black Cohosh, Red Clover, and Magnesium · PCOS Supplement Stack: What the Evidence Actually Supports
Be the first to try Prova
We're building an app to track whether women's hormonal health actually works. Join the waitlist.